Protein synthesis is a complex and highly coordinated process requiring many different protein factors as well as various types of nucleic acids. All translation machinery components require multiple maturation events to be functional. These include post-transcriptional and post-translational modification steps and methylations are the most frequent among these events. In eukaryotes, Trm112, a small protein (COG2835) conserved in all three domains of life, interacts and activates four methyltransferases (Bud23, Trm9, Trm11 and Mtq2) that target different components of the translation machinery (rRNA, tRNAs, release factors). To clarify the function of Trm112 in archaea, we have characterized functionally and structurally its interaction network using Haloferax volcanii as model system. This led us to unravel that methyltransferases are also privileged Trm112 partners in archaea and that this Trm112 network is much more complex than anticipated from eukaryotic studies. Interestingly, among the identified enzymes, some are functionally orthologous to eukaryotic Trm112 partners, emphasizing again the similarity between eukaryotic and archaeal translation machineries. Other partners display some similarities with bacterial methyltransferases, suggesting that Trm112 is a general partner for methyltransferases in all living organisms.
INTRODUCTION
In all living cells, the ribosome nanomachine assisted by tRNAs and translation factors decodes the genetic information contained within messenger RNAs (mRNAs) to synthesize the corresponding proteins. mRNA translation is a highly complex process which in addition to the numerous factors involved, requires RNA and protein maturation events for faithful and timely protein production. Among those events, post-transcriptional modifications are found on all components and in the three domains of life. Indeed, transfer RNAs (tRNAs) are heavily modified with various different chemical structures added on nucleotides, thereby contributing to their stability and to translation accuracy (1) . In eukaryotic and archaeal ribosomal RNAs (rRNAs), modifications such as pseudouridylation or 2 -Omethylation are introduced by RNA-guided multi-protein enzymes (2) while modifications on the bases such as methylation are introduced by protein-only enzymes (3) . These rRNA modifications cluster mostly to functionally important regions of the ribosome (peptidyl transferase center, tRNA and mRNA binding sites, subunit-subunit interface) and hence contribute to its optimal activity (4, 5) . More recently, the N6-methyladenosine (m 6 A) mRNA modification has been the focus of many studies aimed at clarifying the role of this epitranscriptomics modification on mRNA splicing, transport, translation and decay (6) (7) (8) (9) . Finally, translation factors are also subject to many posttranslational events such as methylation. This is indeed the case for uS13, uL5 and eL42 ribosomal proteins ((10); ribosomal proteins are numbered according to the naming proposed by Ban et al. (11) ) as well as translation elongation factors eEF1A, eEF2 and eEF3 (this later is only present in yeasts; (12) (13) (14) (15) (16) (17) ). Bacterial (RF1 and RF2) and eukaryotic (eRF1) class I translation termination factors are also methylated on the glutamine side chain of the universally conserved GGQ motif that interacts with the peptidyl transferase center to trigger the release of the newly synthesized proteins (18) (19) (20) (21) (22) (23) . The methylation of the GGQ motif of the bacterial RF1 and RF2 proteins is catalyzed by PrmC. In eukaryotes, the same motif of eRF1 is modified by a complex formed by the Mtq2 methyltransferase (MTase) catalytic subunit and its activator Trm112 subunit (19, 20, (24) (25) (26) (27) . Interestingly, in Saccharomyces cerevisiae, the Trm112 protein also interacts with and activates three other MTases, namely Bud23, Trm9 and Trm11, which modify factors involved in translation (28) . The Bud23-Trm112 complex and its human ortholog (BUD23-TRMT112 or WBSCR22-TRMT112) catalyze the N7-methylation of G nucleotide (m 7 G) at positions 1575 and 1639 on the yeast and human 18S rRNA, respectively, and these complexes are essential for 40S biogenesis (29) (30) (31) (32) (33) (34) (35) . The Trm11-Trm112 complex catalyzes the addition of a methyl group on nucleotide G10 from several tRNAs to form N2-methylguanosine (m 2 G) thereby most likely contributing to their stability (36, 37) . The Trm9-Trm112 complex and its human ortholog ALKBH8-TRMT112 are involved in the 5-methoxycarbonylmethyluridine (mcm 5 U) modification of the wobble position from the anticodon loop of some tRNAs and hence enhance translational fidelity and efficiency (38) (39) (40) (41) (42) (43) (44) (45) (46) (47) . It is noteworthy that human TRMT112 partners have been associated with diseases and are potential targets for drug developments. Indeed, ALKBH8 protein is highly expressed in a variety of human cancer cells including bladder cancer. Furthermore, ALKBH8 silencing induces apoptosis of urothelial carcinoma cells thereby suppressing tumor growth, angiogenesis and metastasis and also renders the cells sensitive to methyl methane sulfonate (MMS) and to the anti-cancer drug bleomycin (41, 48) . Human BUD23 could be a tumor marker for invasive breast cancer, myeloma cells and hepatocarcinoma (49) (50) (51) and could contribute to lung pathologies (52) .
Bioinformatics analyses have revealed the presence of Trm112 orthologues in bacteria and archaea suggesting that its role might extend outside eukaryotic organisms (25, 28, 36) . While nothing is known on bacterial Trm112 orthologues, the detection of Mtq2, Trm9 and Trm11 orthologues in archaeal genomes together with the strong similarity between eukaryotic and archaeal translation machineries suggest that archaeal Trm112 might play a role similar to the eukaryotic Trm112 (53) (54) (55) . Indeed, Trm11 orthologues (hereafter named aTrm11) from Pyrococcus abyssii and Thermococcus kodakarensis have been biochemically characterized as enzymes methylating guanine nucleotide at position 10 of some tRNAs (56, 57) . However, these two enzymes not only catalyze the formation of N2-methylguanosine but also of N2,2-dimethylguanosine and do not require Trm112 to be active. Regarding Trm9, several observations argue in favor of its presence in some archaea. First, an initial survey of Haloferax volcanii genome suggested that the HVO 0574 gene encodes for a potential Trm9 orthologue (58) but a more recent analysis proposed HVO 1032 gene as a better candidate (59) . Second, genes encoding for proteins displaying some sequence similarity with the various enzymes (Elp3, Tuc1 and Trm9) involved in the formation of mcm 5 s 2 U modification at position 34 of tRNAs are present in H. volcanii and genes for Elp3 and Trm9 orthologues cluster in Sulfolobus solfataricus (58) . Third, studies in the early 90's revealed the presence of unknown modifications at position U 34 of some tRNAs from H. volcanii (60) . Regarding class I release factors, it is striking that despite radically different 3D-structures of the bacterial and eukaryotic factors, dedicated machineries have evolved to methylate the glutamine side chain of the universally conserved GGQ motif. Hence, one can imagine that such modification also exists on archaeal aRF1. Considering the structural similarity between aRF1 and eukaryotic eRF1 factor (61, 62) , the enzyme responsible for this modification is very likely to be orthologous to Mtq2. This is further supported by the presence of an Mtq2 ortholog in all archaeal phyla (25, 28) . Finally, so far, no m 7 G modification of the nucleotide corresponding to S. cerevisiae G 1575 in archaeal 16S rRNA has been found, in agreement with the absence of proteins with significant sequence homology with Bud23 in archaeal genomes (28) .
To clarify the roles of archaeal Trm112, we identified potential partners of Trm112 in the H. volcanii model organism by co-immunoprecipitation followed by mass spectrometry-based proteomic identification. We validated some of these partners, characterized the in vivo and in vitro biochemical functions of two of these and solved the crystal structure of another one. Altogether, our results show that H. volcanii Trm112 (hereafter named HvoTrm112) displays striking similarities with its eukaryotic orthologs but is also able to interact with a much larger number of MTases than the eukaryotic Trm112.
MATERIALS AND METHODS

Deletion of TRM112 and TRM9 genes in H. volcanii
The chromosomal copy of the HVO 1131 gene (hereafter named HVO TRM112) encoding for HvoTrm112 protein was deleted by the pop-in/pop-out method to generate the Haloferax volcanii H98 trm112 strain (HvoMG5; Supplementary Table S1 ) using published protocols (63, 64) . First, two 400 bp fragments covering the upstream (US) and downstream (DS) regions of the HVO TRM112 gene were amplified from H. volcanii genome by PCR using oligonucleotides oMG86/oMG87 and oMG88/oMG89, respectively (Supplementary Table S2 ). The PCR products were then digested with BamHI/XbaI and XhoI/BamHI restriction enzymes, respectively and then cloned into XbaI/XhoI digested plasmid pTA131 to obtain pTA131 containing US-DS of HVO TRM112 (pMG613) used for the pop-in/popout procedure.
Colonies resulting from excision of the plasmid (popout) were screened by colony lift to check for insertion of the Flag-tag sequence. A DIG-labelled PCR product using oligonucleotides oMG320 and oMG321 on genomic DNA was used as a probe, and detected using the DIG Luminescent Detection kit (Roche) and a ChemiDoc MP (BioRad). 52% of the colonies proved to be deleted for HVO TRM112 gene (Supplementary Figure S1A) . Research, 2018, Vol. 46, No. 16 8485 An additional screening was performed by PCR on some colonies using oMG163 and oMG164 oligonucleotides (Supplementary Table S2 ) to amplify the whole upstream and downstream parts of HVO TRM112 gene (Supplementary Figure S1B ). Parts of colonies were picked and lysed by mixing in 50 l water, and then used as DNA templates for PCR reaction. The PCR was performed with Q5 HighFidelity DNA Polymerase (Biolabs), according to manufacturer's instruction (PCR conditions: one 30 s cycle at 98
Nucleic Acids
• C followed by 30 cycles (10 s at 98
• C; 20 s at 62
• C and 30 s at 72
• C) and a final step of 2 min at 72
• C) To study the enzymatic activity of HvoTrm9-Trm112 complex, an H. volcanii H26 strain deleted for the HVO 1032 gene (HvoMG2; Supplementary Table S1), which encodes for the putative Trm9 orthologue, was generated by the pop-in/pop-out method. First, two 400 bp fragments of upstream (US) and downstream (DS) regions surrounding HVO 1032 gene in H. volcanii genome were amplified by PCR using oligonucleotides oMG72/oMG73 and oMG74/oMG75, respectively (Supplementary Table S2). The PCR products were then digested with BamHI/XbaI and XhoI/BamHI restriction enzymes, respectively and then cloned into XbaI/XhoI digested plasmid pTA131 to obtain pTA131 harboring US-DS of HVO 1032 (pMG612). This plasmid was then used for popin/pop-out to delete HVO 1032 gene as described above for the generation of the H. volcanii H98 trm112 strain. PCR were performed on genomic DNA from different colonies using oMG73 and oMG162 (Supplementary Table S2) and revealed that 50% of the colonies were deleted for HVO 1032 gene (Supplementary Figure S2) .
Co-immunoprecipitation of HvoTrm112-Flag protein
To identify HvoTrm112 protein partners, we expressed a Trm112-Flag protein from a plasmid and performed coimmunoprecipitation (co-IP) under cross-linking conditions as described below. First, the HVO TRM112 gene was amplified from H. volcanii genomic DNA using oligonucleotides oMG320/oMG321 (this later includes a sequence encoding for a Flag-tag; Supplementary Table S2 ). The PCR product was digested by NdeI and NotI restriction enzymes and later inserted into pTA962 digested with the same enzymes to yield pMG772. The pMG772 or pMG807 (pTA927-derived plasmid expressing only the Flag-tag as a control; generous gift from Prof. Anita Marchfelder, Ulm University, Germany) plasmids purified from competent dam − E. coli cells were transformed into HvoMG5 strain according to the pop-in procedure described above. The transformants were plated on YPC and incubated at 45
• C for at least 5 days. This resulted in the H. volcanii H98 trm112 HvoTrm112-Flag and trm112 Flag-only strains.
Next, one colony of H. volcanii strain H98 trm112 HvoTrm112-Flag was used to over-express HvoTrm112-Flag. First, the colonies were inoculated to 10 mL YPC (supplemented with thymidine 60 g/mL), incubated O/N at 45
• C and 150 rpm. In the next day, 2.5 ml O/N culture was applied to 1 L YPC (+thymidine 60 g/ml) and grown O/N at 45
• C and 150 rpm. On the third day, 18% SW-dissolved tryptophan was added to the O/N culture to the final concentration of 5 mM, followed by 6 h incubation at 45
• C and 150 rpm for protein over-expression. The cells were harvested by centrifugation at 4000 rpm for 30 min. For the Flag-only control, the same protocol was used for Hvo H98 trm112 Flag-only strain.
Co-IP experiments of HvoTrm112-Flag and of Flag-only were carried out as described in Fischer et al. (65) , with some slight modifications (see supplementary materials for details). Proteomic analysis details are given in the supplementary materials.
In vitro studies of HvoTrm112-MTase complexes
The procedures for cloning, expression and purification of proteins and protein complexes used for in vitro studies (enzymology, SEC-MALLS and X-ray crystallography) are described in supplementary materials. The tRNAs from S. cerevisiae or H. volcanii strains were purified as previously described (47) .
The MTase assays were performed in a total volume of 10 l (for HvoMtq2-Trm112) or 20 l (for HvoTrm9-Trm112) containing 400 mM potassium phosphate buffer pH 7. • C, the reaction was stopped by precipitation with cold trichloroacetic acid (5%), followed by filtration on Whatman GF/C filters. The [ 3 H] incorporation was measured using a Beckman Coulter LS6500 scintillation counter. • C and 24
• C. Crystals appeared within 4-5 h and reached their maximum size (400 m length) within 3 days. Crystals were cryo-protected by transfer into their crystallization condition supplemented with progressively higher glycerol concentration up to 30% and then flash-frozen in liquid nitrogen.
All datasets were collected on beam-line Proxima-2A (Synchrotron SOLEIL, Saint-Aubin, France) at 100 K. The structure was solved by Sulfur-SAD (Single Anomalous Dispersion) using a highly redundant dataset (seven datasets of 1400
• each collected on different regions of a single crystal) collected at 2.0664Å to get strong anomalous signal from sulfur atoms (see Supplementary Table S3 for statistics). A 1.35Å resolution dataset was obtained by merging two datasets collected at different crystal-detector distances on another crystal (Supplementary Table S3 ). Data were processed with XDS (66) and scaled using XS-CALE. All crystals belonged to space group P2 1 2 1 2 1 with two copies of Hvo 0019-Trm112 complex per asymmetric unit. Twenty-four sulfur sites (eleven per Hvo 0019-Trm112 complex and two from S-adenosyl-L-homocysteine (SAH) molecules bound to Hvo 0019 methyltransferase) were successfully located using SHELXD (67) . Experimental phasing followed by density modification were performed with the PHASER EP and RESOLVE programs implemented in the PHENIX suite (68) (69) (70) (71) . The final model was obtained by iterative cycles of building and refinement performed using COOT (72) and BUSTER (73) programs, respectively (Supplementary Table S3 ). The final model for Hvo 0019-Trm112 complex contains Hvo 0019 residues 2-227 (including the first histidine from the His 6 -tag) and 2-12, 15-231 (including five histidine residues from the His 6 -tag) for protomers A and B, respectively as well as HvoTrm112 residues 1-59 and 1-25, 29-58 for protomers C and D, respectively. In addition, 387 water molecules, two SAH molecules and two glycerol molecules from the cryoprotectant solution have also been modeled. The coordinates and structure factors files are available from the Protein Data Bank (PDB) under accession code 6F5Z.
RESULTS
Identification of several partners of HvoTrm112 protein by co-immunoprecipitation and proteomics
HvoTrm112 protein partners were isolated by coimmunoprecipitation (co-IP) of Flag-tagged HvoTrm112 ( Figure 1A ). For this purpose, we deleted the TRM112 gene in the H. volcanii H98 background by the pop-in/pop-out method as described in the methods section. Among all colonies, 52% lacked this gene indicating that TRM112 is not an essential gene (Supplementary Figure S1A and B). The deletion of this gene did not affect generation time but resulted in much smaller colonies (Supplementary Figure S1C and D) . The H. volcanii trm112Δ strain was then transformed with a plasmid encoding a C-terminally Flag-tagged version of HvoTrm112 under the control of tryptophan inducible promoter. The trm112Δ strain was also transformed with a plasmid expressing only the Flag-tag (kind gift from Prof. Anita Marchfelder, Ulm University, Germany) as negative control. Before cell lysis, an in vivo cross-linking step was performed in the co-IP protocol by adding 1% formaldehyde as described by Fischer and colleagues (65). This step was added for the following reasons. First, an initial co-IP experiment with no cross-linking resulted in a low number of specific peptide spectra in the mass spectrometry analysis (data not shown). Second, HvoTrm112 could interact with some of its partners in a transient manner. Third, protein-protein interactions in this organism might be maintained by high salt concentration while the low salt concentration used during the co-IP protocol could induce complex dissociation and/or result in protein aggregation ( Figure  1A ). Proteins co-immunoprecipitated with HvoTrm112-Flag or with the Flag-tag control were identified by mass spectrometry as described in the Supplemental methods. This revealed that the cross-linking step resulted in an increased number of proteins identified by mass spectrometry coupled to a higher number of specific peptide MS/MS spectra.
As suggested by the SDS-PAGE analysis of the co-IP results ( Figure 1B and Supplementary Figure S3 ), >1000 proteins were identified by the LC-MS/MS analyses of four independent co-immunoprecipitation experiments of HvoTrm112-Flag whereas only a few hundreds were identified in the negative control experiments with the Flag-only construct (Supplementary Table S4 ). To reduce this extensive list, a series of stringent MS-based criteria (see supplemental information) were applied to select the most confident protein candidates. In addition, proteins already identified by Fischer et al. (65) in their co-immunoprecipitation of HvoLsm-Flag (performed in identical conditions to those used in our study) were considered as non-specific interacting partners (most probably, highly abundant proteins) and were removed. Those strict filtering criteria led to a final list of 499 proteins (Supplementary Table S5 ).
We then ranked these proteins based on their Normalized Spectral Abundance Factor (NSAF; (74)) and observed that HvoTrm112 exhibited the higher NSAF value in agreement with its role as bait protein (Table 1) (75) and one is not a SAM-dependent enzyme (MetE1). Hence, the HvoTrm112 interaction network shares common features with the eukaryotic Trm112 interactome but might be more complex.
Validation of several HvoTrm112-MTase complexes
To validate the co-IP and proteomic results, a subset of the identified SAM-dependent class I MTases was selected to test whether they are indeed bona fide binding partners of HvoTrm112. In addition to the H. volcanii homologs of the known eukaryotic Trm112 partners, namely HvoMtq2, HvoTrm9 and HvoTrm11, six other MTases were chosen: Hvo 0773 (exhibiting the highest NSAF value among the detected MTases), Hvo 0475, Hvo 0574 (initially proposed to be the Trm9 archaeal orthologue (58) Figure S4B) . Next, we performed a 3-steps (Ni-NTA, ion-exchange and size-exclusion chromatographies) purification protocol from E. coli cultures co-expressing each His-tagged MTase with HvoTrm112. In all cases but HvoTrm11 (see below), at the end of this stringent purification protocol, we could observe a second major band, migrating at the expected size for HvoTrm112 in addition to the band corresponding to the tagged MTase. Mass spectrometry analyses confirmed that for each MTase tested, these bands correspond to both the MTase of interest and to HvoTrm112 (data not shown Figure S4C) . Hence, we cannot conclude about the direct interaction between HvoTrm11 and HvoTrm112. We thus conclude that in H. volcanii, Trm112 interacts directly with at least eight different MTases (HvoMtq2, HvoTrm9, Hvo 0019, Hvo 0773, Hvo 0574, Hvo 0475, Hvo 2875 and Hvo 1715). Its interaction network is then much more complex than for its eukaryotic orthologs studied so far (28) .
Characterization of HvoMtq2-Trm112 and HvoTrm9-
Trm112 enzymatic activities
Among all these HvoTrm112 partners, there are clear orthologues for two eukaryotic Trm112 partners, namely Mtq2 and Trm9, paving the way towards their functional characterization.
In eukaryotes, the Mtq2-Trm112 complex is enzymatically active on class I translation termination factor eRF1 but only when this later exists as a complex with the GTP-bound form of class II translation termination factor eRF3 (25, 26) . To characterize the enzymatic activity of the recombinant HvoMtq2-Trm112 complex in vitro, we over-expressed in E. coli and purified both HvoaRF1 and HvoaRF3 (also known as HvoaEF1A). First, the HvoaRF1 methylation activity of the HvoMtq2-Trm112 complex, in the presence of HvoaRF3 and GTP, was measured both in the absence and presence of KCl (3M), the latter corresponding to physiological conditions (76) . In agreement with several reports on H. volcanii enzymes, a strong methylation activity was detected only in the presence of KCl (Figure 2A) . In these conditions, HvoMtq2-Trm112 complex catalyzes the methylation of nearly 26 pmol of HvoaRF1 out of 100 pmol in 2 h. To rule out the possibility that the detected enzymatic activity resulted from an E. coli contaminant, we substituted Tyr111 from the NPPY signature in HvoMtq2 by Ala with the aim of inactivating the HvoMtq2-Trm112 complex as the corresponding S. cerevisiae Mtq2 mutant is completely inactive (27) . No enzymatic activity could indeed be detected for this Y111A HvoMtq2-Trm112 mutant (Figure 2A ). In addition, substitution of Gln187 in the HvoaRF1 GGQ motif to Ala also resulted in undetectable activity. Finally, both HvoaRF3 and GTP were necessary for methylation of HvoaRF1 by the HvoMtq2-Trm112 complex. Next, we investigated the in vivo methylation state of the HvoaRF1 GGQ motif in different H. volcanii strains. First, we deleted HvoMTQ2 gene in H. volcanii and observed that this deletion severely affects the generation time (251 minutes compared to 128 minutes for wild-type; Supplementary Figure S1C ) and results in small size colonies (similarly to trm112Δ strains). Hence, as previously described in S. cerevisiae (20, 42) , the MTQ2 gene is also important for optimal growth in H. volcanii. Second, we introduced a Flag-tag at the C-terminal extremity of the HvoaRF1 protein in the three following strains: WT, mtq2Δ and trm112Δ and purified HvoaRF1-Flag from these three strains. Using mass spectrometry, we analyzed for the presence of a methyl group on the GGQ motif of these endogenous HvoaRF1 proteins. We could detect the presence of a methyl group on the glutamine residue of the GGQ motif on the HvoaRF1 protein purified from WT and trm112Δ strains but not from the mtq2Δ strain ( Figure 2B , C and Supplementary Figure  S6 ). As control, we expressed HvoaRF1 in E. coli, purified it and incubated it with the HvoMtq2-Trm112 holoenzyme under optimal conditions for in vitro enzymatic activity. Mass spectrometry analyses revealed the presence of methylated glutamine only on HvoaRF1 protein incubated with the HvoMtq2-Trm112 holoenzyme ( Figure 2B and Supplementary Figure S6 ).
Altogether, this demonstrates that HvoMtq2-Trm112 holoenzyme catalyzes the methylation of the glutamine side chain from the HvoaRF1 GGQ motif in an HvoaRF3-and GTP-dependent manner similarly to its yeast and human orthologs (25, 26) . This also reveals that in H. volcanii,
Mtq2 is mandatory for HvoaRF1 methylation in vivo while
Trm112 is not, explaining the strong differences in generation times between the trm112Δ and mtq2Δ strains (251 ± 13 min versus 123 ± 6 min, respectively; Supplementary Figure S1C ).
In parallel, we investigated whether the HvoTrm9-Trm112 acts as a tRNA modification enzyme similarly to its eukaryotic ortholog. To obtain putative tRNA substrates, we generated an H. volcanii H26 strain deleted for the HVO 1032 gene (hereafter termed H. volcanii trm9Δ), which encodes for HvoTrm9, by the pop-in/popout method as described above for the H. volcanii trm112Δ strain construction. 50% of the colonies obtained after plasmid excision (pop-out) were deleted for HvoTRM9 gene (3 out of 6 tested, Supplementary Figure S2 ). Our ability to obtain this deletion mutant indicates that the gene encoding for HvoTrm9 is not essential. Contrary to the deletion of H. volcanii TRM112 gene, the deletion of HvoTRM9 gene did not affect the size of the colonies but resulted in an affected generation time (178 min compared to 128 min for wild-type H. volcanii strain; Supplementary Figure S1C, D) . Total tRNAs purified from this strain as well as those purified from S. cerevisiae trm9Δ or elp1Δ strains (47) were used for in vitro enzymatic assays. Surprisingly, the HvoTrm9-Trm112 complex was active on total tRNAs from S. cerevisiae trm9Δ strain as substrates but not from H. volcanii trm9Δ strain ( Figure 3A) . HvoTrm9-Trm112 complex (2 pmol) modifies up to 5.5 pmol of tRNAs from S. cerevisiae trm9Δ strain out of 100 pmol while S. cerevisiae Trm112-Trm9 complex (1.5 pmol) was modifying up to 7 pmol (out of 75 pmol) of the same tRNAs (47) . As observed for HvoMtq2-Trm112 complex, HvoTrm9-Trm112 complex is significantly more active in the presence of 3 M KCl than in the absence of KCl, where only ∼1.5 pmol of tRNAs are modified. Its activity depends on the presence of the cm 5 U (5-carboxymethyluridine) modification at position 34 of tRNA anticodon loop as tRNAs purified from S. cerevisiae elp1Δ strain are not substrates of this complex. Finally, as Hvo 0574 gene product, which also interacts with HvoTrm112, was initially predicted to be orthologous to eukaryotic Trm9 (58), we have included this purified complex in our enzymatic assays. As shown in Figure 3A , this complex does not exhibit enzymatic activity on total tRNAs extracted from either S. cerevisiae trm9Δ or H. volcanii trm9Δ strains. Table S9 ) measured for the cm 5 U standard (top) and for the unknown molecule eluted 1 minute later than cm 5 U in the digested WT tRNAs sample (bottom).
Next, we have tried to clarify our surprising observation that tRNAs extracted from the H. volcanii trm9Δ strain are not substrates of the HvoTrm9-Trm112 complex and to document the chemical nature of the yet uncharacterized modifications found at U 34 (60, 77) ). We then performed nucleoside analyses following total digestion of tRNAs extracted from H. volcanii WT, trm9Δ or trm112Δ strains by reversed phase LC-MS/MS. This revealed that the mcm 5 U (5-methoxycarbonylmethyluridine) nucleoside exists only in tRNAs from WT but neither from trm9Δ nor trm112Δ strains ( Figure 3B ). In parallel, the assay showed no presence of cm 5 U in the tRNAs extracted from all these strains at the retention time of the standard ( Figure 3C ). Interestingly, a second peak was detected in the assay having the same transition as cm 5 U yet eluting a minute later. We found the later eluting peak to have a different ion ratio to that of the cm 5 U standard indicating this was not cm 5 U (Figure 3C-D) . To further verify the absence of cm 5 U in the original sample, a 500 ng spike of cm 5 U standard was added to the WT strain and subjected to analysis (Supplementary Figure S7 ). This showed the presence of the cm 5 U spike as well as the later eluting peak with their respec-tive ion ratio. While the later eluting peak has not been identified in this work, it is clear that all samples lacked the cm 5 U modification. To our knowledge, these results demonstrate for the first time that the mcm 5 U modification exists in H. volcanii and most probably in other archaea with a Trm9 ortholog. They also show that both HvoTrm9 and HvoTrm112 proteins are necessary for the formation of mcm 5 U in vivo. Finally, these analyses rationalize the lack of enzymatic activity of the HvoTrm9-Trm112 complex on tRNAs purified from the trm9Δ H. volcanii strain due to the absence of the cm 5 U Trm9 substrate in those tRNAs. This strongly indicates that in the absence of HvoTrm9 or HvoTrm112, cm 5 U is rapidly converted into other chemical structures (such as for instance, ncm 5 U as previously observed in Δtrm9 S. cerevisiae strain (44) ) that remain to be identified. Altogether, these results demonstrate that the HvoTrm9-Trm112 complex is indeed a tRNA methyltransferase, which, similarly to its eukaryotic ortholog, modifies cm 5 U into mcm 5 U (5-methoxycarbonylmethyluridine) at position 34 of the tRNAs as the cm 5 U modification, catalyzed by the Elp1-6 complex in eukaryotes (78, 79) , is required for enzymatic activity.
Structure of a Trm112-MTase complex from H. volcanii
To gain insight into the molecular bases responsible for the interaction between HvoTrm112 and its interacting MTase partners, different HvoTrm112-MTase complexes were subjected to crystallization trials in the presence or in the absence of SAM. Crystals diffracting up to 1.35Å resolution were obtained for the Hvo 0019-Trm112 complex. The structure of this complex was solved at 2.5Å resolution by the Sulfur-SAD method (Supplementary Figure S8) by taking advantage of the high number of sulfur atoms in this complex (11, excluding the initial methionine from Hvo 0019, which is very likely to be excised in E. coli (80) ). The structure was further refined at high resolution using a 1.35Å resolution native dataset to yield a final model with R and R free values of 18.5% and 20.7%, respectively. There are two virtually identical copies of the Hvo 0019-Trm112 complex in the asymmetric unit ( Figure 4A ; rmsd value of 0.27Å over 211 C␣ atoms). Each complex is bound to a SAH molecule, most probably co-purified with Hvo 0019-Trm112 complex.
Structurally, Hvo 0019 adopts the typical class-I SAMdependent MTase fold composed of a central seven stranded ␤-sheet surrounded by three ␣-helices (the Cterminal half of ␣Z, ␣A and ␣B) on one side and two on the other side (␣D, ␣E; Figure 4B ). On top of the central ␤-sheet, four ␣-helices (␣Y, the N-terminal half of ␣Z, ␣1 and ␣2) contribute to the formation of a cavity centered on the sulfur atom from the SAH molecule bound to the Hvo 0019 protein. SAH binds in a canonical manner compared to what was observed for other class I SAM-dependent MTases. HvoTrm112 structure consists of only the zinc knuckle domain previously observed in eukaryotic Trm112 proteins (rmsd values of 1.1-1.4Å over around 55 C␣ atoms; (25, 27, 33, 47) ), including a small Nterminal ␣-helix (␣1) and a four-stranded anti-parallel ␤-sheet ( Figure 4B ). Contrary to eukaryotic Trm112 proteins and some structurally similar bacterial proteins (PDB code: 2KPI) of known structures, there is no zinc atom bound to HvoTrm112 in agreement with the absence of conservation of the cysteine residues involved in zinc coordination. The interface between HvoTrm112 and Hvo 0019 has an overall area of 975Å 2 and is slightly smaller than the previously described interfaces between eukaryotic Trm112 and its MTase partners (33, 47) . This most likely results from the absence of the helical domain, specific to eukaryotic Trm112 proteins, that was in part contributing to these interactions. Complex formation involves 20 and 21 residues from HvoTrm112 and Hvo 0019, respectively (Supplementary Figure S9 ). The core of this interface is formed by hydrophobic residues (M1, L5, I8, L9, P12, I50, P51, L53, L54, P55 and M58 from HvoTrm112 and F66, F89, L90, V91, L97, P98 and F99 from Hvo 0019; Supplementary Figure S9) . Such a large hydrophobic interface rationalizes the strong solubilization effect that we observe for HvoTrm112 upon co-expression with Hvo 0019 in E. coli (Supplementary Figure S4A ). This hydrophobic core is surrounded by polar residues (K2, D7, C10, K15, E29, N52 and R59 from HvoTrm112 and S2, R64, Q76, R79, D85, D86, S88, D93, D96, D100, S103, E125 and R128 from Hvo 0019). Six hydrogen bonds and three salt bridges are also observed at the interface (Supplementary Table S6 ). Two hydrogen bonds formed between main chain atoms of V91 from Hvo 0019 with P51 as well as L53 from HvoTrm112, are responsible for the formation of a ␤-zipper interaction between HvoTrm112 strand ␤4 and Hvo 0019 strand ␤3 ( Figure 4B ). Other hydrogen bonds are formed between P98, L97, R64 and D100 from Hvo 0019 and C10, K15, S4 and I8 from HvoTrm112, respectively. Finally, salt bridges are formed by K15 from HvoTrm112 with D96 and E125 from Hvo 0019, and by D7 from HvoTrm112 with R64 from Hvo 0019.
As stated above, there are two copies of Hvo 0019-Trm112 complex in the asymmetric unit and these are related by a two-fold symmetry axis ( Figure 4A ). These copies interact together through a large surface area of 840Å 2 . As SEC-MALLS measurements on this complex have revealed that it forms heterotetramer in solution (Supplementary Figure S5 ; Table 2 ), this contact area most likely corresponds to the biological interface responsible for this oligomeric state. This homodimerization interface is exclusively formed by residues from Hvo 0019, more precisely from strands ␤6 and ␤7 and helix ␣Z. Hence, the MTase partner seems to govern the formation of oligomeric states, explaining why depending on the MTase, HvoTrm112-MTase complexes are either heterodimers, heterotetramers or heterohexamers in solution (Table 2) .
BLAST searches for proteins sharing sequence similarity with Hvo 0019 identified orthologous proteins mostly from specific archaeal phyla such as halobacteriales and thaumarchaeota but also from some bacteria (Legionella shakespearei, Agrobacterium tumefaciens, rhodobacteriaceae, flavobacteriaceae, acidobacteria). Multiple sequence alignments revealed the presence of few highly conserved residues (Supplementary Figure S9B) . Interestingly, in Hvo 0019 structure, these residues cluster around the expected position of the SAM methyl group and form a strongly conserved pocket, which is very likely to correspond to the enzyme active site ( Figure 4C ). Comparison of Hvo 0019 protein structure with previously described struc- tures of MTases revealed a significant degree of conservation with the active site of NodS MTase from Bradyrhizobium japonicum (81) . NodS is involved in the biosynthesis of the Nod factor, a modified chitosaccharide acting as a signal molecule in rhizobia. It is catalyzing the methylation of the NH 2 group of Nod glucosamine moiety. Indeed, residues R22, E111, Y114, Y115 and W152 from Hvo 0019 structurally match with R21, E115, Y118, Y119 and W156 from NodS, respectively ( Figure 4D ). In addition, the side chains from Hvo 0019 W10 and NodS W20 are also in close vicinity. Altogether, this suggests that Hvo 0019 might modify a substrate with a hexose sugar ring. Further studies will be needed to characterize the enzymatic activity of the Hvo 0019-Trm112 complex.
DISCUSSION
Protein translation is one of the most intricate processes in cell biology and requires numerous factors acting in a highly coordinated choreography. Most of these translational factors (tRNAs, rRNAs and proteins) are frequently subjected to post-transcriptional and post-translational modifications to perform correct functions. Methylation is so far known as the most prevalent modification of translation machinery. In yeast, effects of methylation on translation are perfectly illustrated by Trm112, an obligate activator for at least four methyltransferases contributing to ribosome biogenesis and function. The importance of this interacting network is also reflected by its conservation in human where these MTases are associated with diseases (28) . Sequence analyses revealed that Trm112 orthologues are also found in archaea and bacteria. As most of the translational machinery components are very similar between eukaryotes and archaea, this raised the question of the existence of a similar Trm112 interacting network in archaea.
One protein, many MTase partners
In S. cerevisiae and human, Trm112/TRMT112 is known to directly interact with at least four class I SAM-dependent MTases, namely Bud23/BUD23, Trm9/ALKBH8, Trm11/TRMT11 and Mtq2/HEMK2 (28 Figure S5) . Hence, H. volcanii, and probably more generally archaeal, Trm112 interaction network is larger than anticipated from our current knowledge in eukaryotes, and we cannot exclude that additional MTase partners listed in Table 1 await for experimental validation. Our experimental approach proved very powerful as only three potential partners could have been identified by bioinformatics analyses based on their similarity with eukaryotic Mtq2, Trm9 and Trm11 proteins (no Bud23 ortholog could be found in H. volcanii and in archaea in general; (28, 59) ). These three MTases are found as potential HvoTrm112 partners in our co-IP experiments but we could validate their interaction with HvoTrm112 only for HvoTrm9 and HvoMtq2 as we were unable to over-express HvoTrm11 in a soluble form in E. coli. The presence of HvoTrm11 in the list of putative partners was somehow surprising as the orthologous proteins from two archaea (P. abyssii and T. kodakarensis) were previously shown to be sufficient to catalyze the mono-and di-methylation of G 10 on some tRNAs in vitro (56, 57) . This could be explained by our recent analysis of the distribution of Trm112 orthologues within archaeal genomes. Indeed, Trm112 is absent in thermococcales and methanobacteriales, which include Pyrococcus abyssii and Thermococcus kodakarensis (28) . Hence, we propose that when present in an archaeal organism, aTrm112 interacts directly with aTrm11 while when absent, aTrm11 has evolved to be active on its own. Studies aimed at clarifying this aspect are in progress.
The identification of at least six additional MTases able to directly interact with HvoTrm112, which is only composed of 61 amino acids, was completely unexpected. Bioinformatics analyses revealed that among those, three (Hvo 0773, Hvo 0475 and Hvo 0574) might be specific for halobacteriales phylum from euryarcheota, which includes H. volcanii. Figure S9B) . Similarly, proteins sharing significant sequence identity with Hvo 1715 are present in Bacilli (such as Bacillus anthracis and Streptococcus pneumoniae) and in mycobacteria. This is also the case for Hvo 2875 present in nocardia. This suggests that in bacteria, Trm112 orthologues could also interact with MTases. This is further supported by several observations. First, the structures of bacterial Trm112 orthologues (PDB codes: 2KPI and 2JS4) are highly similar to the zincknuckle domains from H. volcanii and eukaryotic Trm112 proteins (rmsd of 1.4 to 1.8Å). Second, superimposition of these bacterial structures onto those of Trm112-MTase complexes reveals that the Trm112 region involved in the interaction with MTases adopts the same structure in bacterial proteins and hence is compatible with MTase binding (28) . Third, in some bacteria, genes encoding for Trm112 and MTases are fused and this is often an indication of physical interaction. Finally, a recent study aimed at identifying protein-protein interactions in Desulfovibrio vulgaris detected that Trm112 orthologue (DVU0656) interacts with three MTases (HemK, UbiE and Sun), some of which could also have a role in translation (82) .
Structural studies of eukaryotic Trm112-MTase complexes have shown that all these MTases interact in a very similar way with Trm112 and hence directly compete (27, 33, 37, 47) . The crystal structure of the Hvo 0019-Trm112 complex solved here reveals striking similarities between archaea and eukaryotes. Indeed, Hvo 0019-Trm112 and eukaryotic Trm112-MTase complexes superimpose almost perfectly ( Figure 5A ; rmsd values ranging from 1.7 A to 2.15Å between the different heterodimers). A first hallmark common to all these complexes is the presence of a parallel ␤-zipper interaction formed between Trm112 strand ␤4 and MTase strand ␤3 ( Figure 5A ). The formation of this ␤-zipper relies on hydrogen bonds between amino acid main chain atoms from both partners and hence is less affected by substitutions of amino acid located in the MTase strand ␤4. This very likely explains that Trm112 proteins can have many partners adopting the same overall fold. A second conserved feature between eukaryotic and archaeal Trm112-MTase complexes is the presence of a hydrophobic core at the complex interface, which most likely rationalizes the solubilizing and stabilizing effects observed for Trm112 on several MTases (Supplementary Figure S4A; (25, 30, 42) ). We propose that as in eukaryotes, all identified HvoMTases compete and interact in a very similar mode with HvoTrm112. This is further supported by the fact that all these archaeal MTases are SAMdependent class I MTases and hence adopt the same overall three-dimensional structure. In addition, the comparison of Hvo 0019 residues directly contacting HvoTrm112 with the structurally equivalent residues in all other HvoTrm112 MTase partners identified here, highlights a significant degree of conservation ( Figure 5B ). Indeed, positions forming the hydrophobic core at the interface between Hvo 0019 and HvoTrm112 are largely occupied by hydrophobic residues in the other HvoTrm112 MTase partners.
Then, similarly to what was described for eukaryotic Trm112 proteins, SAM-dependent class I MTases appear as privileged Trm112 partners in archaea. As some of these MTases are not strictly conserved within the archaeal domain of life, the number of MTase partners may vary between archaea. Finally, the similarities found for some of these archaeal proteins with bacterial MTases further suggest that Trm112 interacts with MTases in the three domains of life and that their interaction mode is conserved.
Functional characterization of translation-related complexes
Among the MTases validated as HvoTrm112 partners, two (HvoMtq2 and HvoTrm9) have convincing assigned functions based on their significant sequence similarity with eukaryotic proteins. We have experimentally demonstrated the biochemical functions of HvoMtq2-Trm112 and HvoTrm9-Trm112 complexes both in vitro and in vivo based on our current knowledge of biochemical functions of eukaryotic Mtq2-Trm112 and Trm9-Trm112 complexes.
First, we have shown that the HvoMtq2-Trm112 complex exhibits an in vitro MTase activity on wild-type (but not on the GGA mutant of the universally conserved GGQ motif) class I release factor aRF1 only in the presence of 3M KCl, a common trend of H. volcanii enzymes (Figure 2A) . As observed for yeast and human Trm112-Mtq2 complexes, this activity is dependent on the presence of the GTPbound form of class II translation termination factor aRF3 (25, 26) . This reflects the high similarity between eukaryotic and archaeal translation termination factors eRF1/aRF1 and eRF3/aRF3 (62) . We also demonstrate that HvoaRF1 is methylated on the glutamine side chain of its GGQ motif in H. volcanii cells and that this modification requires HvoMtq2 protein but not HvoTrm112 (Figure 2B and C) . As HvoMtq2 orthologues are found in all archaea (28), we propose that the glutamine side chain of the universally conserved GGQ motif from aRF1 is methylated in archaea in general. The conservation of this post-translational modification in the three domains of life strongly argues in favor of an important biological role. Indeed, despite radically different structures of bacterial RF1/RF2 on one side and eRF1/aRF1 on the other side, these organisms have independently evolved enzymatic machineries to add a methyl group on the NH 2 group of the glutamine side chain of their universally conserved GGQ motif (24, 62, 83) . In bacteria, the methylation of RF1/RF2 GGQ motif by PrmC has been shown to be important for normal growth, to increase the affinity of RF1/RF2 for ribosomes and to enhance translation termination (84, 85) . In eukaryotes and archaea, the role of this modification still remains to be clarified. However, the growth defect phenotype observed in S. cerevisiae and H. volcanii upon deletion of MTQ2 gene ((20) , this study) together with the conservation of this modification in eukaryotes and archaea argue in favor of a strong functional importance for this post-translational modification.
We have also reconstituted a tRNA MTase activity for HvoTrm9-Trm112 complex in vitro but only using tRNAs purified from a trm9Δ S. cerevisiae strain as substrate. As observed for HvoMtq2-Trm112, this enzymatic activity is salt-dependent ( Figure 3A) . The strict requirement of the cm 5 U modification at position 34 of tRNAs indicates that HvoTrm9-Trm112 complex catalyzes the formation of mcm 5 U 34 similarly to eukaryotic Trm9-Trm112 complexes (42, 44, 47) . This is further supported by the detection of the mcm 5 U nucleoside in tRNAs purified from WT but not from trm9Δ or trm112Δ strains ( Figure 3B ). To our knowledge, this is the first experimental evidence for the existence of the mcm 5 U modification in archaeal tRNAs. Surprisingly, tRNAs purified from a Δtrm9 H. volcanii strain were not substrates for the HvoTrm9-Trm112 complex. Indeed, we did not detect the cm 5 U modification, the known substrate of the Trm9-Trm112 complex, in tRNAs from both H. volcanii trm9Δ or trm112Δ strains (Figure 3C-D) , indicating that this cm 5 U intermediate is unstable and rapidly converted into another modification, which could be ncm 5 U, similarly to what has been observed for some tRNAs in yeast (44) . It is noteworthy that this modification, which biosynthetic pathway remains obscure, has been detected in tRNA Leu(UAG) from T. acidophilum archaeon (86) . Further studies will be needed to precisely characterize the chemical structures of the modifications found at position U 34 from other H. volcanii tRNAs but also more generally in archaea. Due to the highly polar nature of modified uridines, which results in low ionization efficiency, this is very likely to be challenging. Hence, the similarity between archaeal HvoTrm112 and its eukaryotic orthologues is not solely restricted to its ability to interact with class I dependent MTases but also extends to the in vivo and in vitro biochemical functions of at least two MTase partners (HvoTrm9 and HvoMtq2) and most probably HvoTrm11, which all modify components contributing to mRNA translation. Together with the strong enrichment of translation factors or ribosome components in our co-IP experiments, this supports an important role of archaeal Trm112 in translation and strengthens the analogies between eukaryotic and archaeal translation apparatus.
CONCLUSION
Trm112 proteins, which are found in the three domains of life, have been characterized exclusively in eukaryotes so far, where these are partners and activators of several MTases modifying factors of the protein synthesis machinery. Here, we have characterized Trm112 network in archaea using Haloferax volcanii as model organism. In this organism, Trm112 interacts with at least eight different MTases. Some exhibit similar functions as their eukaryotic orthologues, further supporting the similarities between eukaryotic and archaeal translation machineries. Other MTases are orthologous to bacterial proteins, strongly suggesting that bacterial Trm112 proteins might also interact with MTases, in agreement with a recent study (82) .
Members of Trm112 family are not unique in their ability to interact with several MTases. Indeed, it has been shown that Vea protein from Aspergillus nidulans acts as a hub protein interacting with at least four MTases, some of which being involved in development, secondary metabolism and fungal pathogenicity (87, 88) . Hence, precise understanding of molecular details ruling the association of a single protein with various proteins adopting the same fold but exhibiting low sequence identity is of importance to decipher the numerous interaction networks that contribute to most cellular pathways (89, 90) .
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